Effects of pulsatile perfusion on human saphenous vein vasoreactivity: A preliminary report

Vascular

Volumn 4, Issue 2, 1996, Pages 143-149

  Schwartz, L B ^a   Purut, C M ^a   Massey, M F ^a   Pence, J C ^a   Smith, P K ^a   McCann, R L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

contractility; pulsatility; vasoreactivity; veins; venous physiology

Indexed keywords

ACETYLCHOLINE; CALCIMYCIN; HISTAMINE; IONOMYCIN; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE;

ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL REACTIVITY; BYPASS SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PULSATILE FLOW; REVASCULARIZATION; SAPHENOUS VEIN;

EID: 0029880097     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099600400206     Document Type: Article

References (40)

1. Chervu A, Moore WS. An overview of intimal hyperplasia. Surg Gynecol Obstet 1990; 171: 433–447.
2. Seidel CL, Lewis RM, Bowers R, et al. Adaptation of canine saphenous veins to grafting: Correlation of contractility and contractile protein content. Circ Res 1984; 55: 102–109.
3. Miller VM, Reigel MM, Hollier LH, Vanhoutte PM. Endothelium-dependent responses in autogenous femoral veins grafted into the arterial circulation of the dog. J Clin Invest 1987; 80: 1350–1357.
4. Makhoul RG, Davis WS, Mikat EM, McCann R, Hagen P-O. Responsiveness of vein bypass grafts to stimulation with Responsiveness of vein bypass grafts to stimulation with norepinephrine and 5-hydroxytryptamine. J Vasc Surg 1987; 6: 32–38.
5. Cross KS, El-Sanadiki MN, Murray JJ, Mikat EM, McCann RL, Hagen PO. Functional abnormalities of experimental autogenous vein graft neoendothelium. Ann Surg 1988; 208: 631–638.
6. Fann JI, Sokoloff MH, Sarris GE, Yun KL, Kosek JC, Miller DC. The reversibility of canine vein-graft arterialization. Circulation 1990; 82 (suppl IV): IV9–18.
7. El-Sanadiki MN, Cross KS, Murray JJ, et al. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Ann Surg 1990; 212: 87–96.
8. Radic ZS, O'Donohoe MK, Schwartz LB, et al. Alterations in serotonergic receptor expression in experimental vein grafts. J Vasc Surg 1991; 14: 40–47.
9. O'Donohoe MK, Radie ZS, Stein AD, Schwartz LB, McCann RL, Hagen P-O. Loss of tachyphylaxis and increased sensitivity to angiotensin II in experimental vein grafts. Vasc Surg 1991; 25: 281–288.
10. Park TC, Harker CT, Edwards JM, Moneta GL, Taylor LM, Porter JM. Human saphenous veins grafted into the arterial circulation demonstrate altered smooth muscle and endothelial responses (abstract). J Vasc Surg 1992; 15: 1067.
11. Miller VM, Bower TC, McCullough JL, Gloviczki P, Vanhoutte PM. Endothelium-dependent responses in nonreversed (in situ) vein grafts. J Vasc Med Biol 1990; 2: 155–162.
12. Komori K, Gloviczki P, Bourchier RG, Miller VM, Vanhoutte PM. Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts. J Vasc Surg 1990; 12: 139–147.
13. Komori K, Schini VB, Gloviczki P, Bourchier RG, Vanhoutte PM. The impairment of endothelium-dependent relaxations in reversed vein grafts is associated with a reduced production of cyclic guanosine monophosphate. J Vasc Surg 1991; 14: 67–75.
14. O'Donohoe MK, Radic ZS, Schwartz LB, Mikat EM, McCann RL, Hagen P-O. Systemic hypertension alters vasomotor function in experimental vein grafts. J Vasc Surg 1991; 14: 30–39.
15. Jawien A, Clowes AW. Anastomotic neointimal hyperplasia and progression of atherosclerosis after arterial repair. In: Bernhard VM, Towne JB, eds, Complications in Vascular Surgery. St. Louis: Quality Medical Publishing, 1991: 55–64.
16. Schwartz LB, Pence JC, Kerns BJ, Iglehart JD, McCann RL, Hagen P-O. Kinetics of experimental vein graft division and function. Surg Forum 1991; 27: 363–365.
17. Massey MF, Davies MG, Klyachkin ML, et al. Modulation of bradykinin receptor expression in experimental vein graft (abstract). FASEB J 1992; 6: A1042.
18. Thulesius O, Gjöres JE. Reactions of venous smooth muscle in normal men and patients with varicose veins. I. Studies on active and passive tension in isolated human vein preparations. Angiology 1974; 25: 145–154.
19. Rice AJ, Leeson CR, Long JP. Localization of venoconstrictor responses. J Pharmacol Exp Ther 1966; 154: 539–545.
20. Haines LJ, Schwartz LB, Massey MF, Kerfoot WW, McCann RL, Hagen P-O. Rabbit external jugular vein vasoreactivity is dependent on segment length and location (abstract). Arteriosclerosis and Thrombosis 1991; 11: 1517A.
21. Rapoport RM, Bevan JA. Effect of contraction of the subsequent responsiveness and maximum contractility of the rabbit ear artery and saphenous vein in vitro. Blood Vessels 1983; 20: 44–55.
22. Finney DJ. Statistical Method of Biological Assay. 3rd ed. London: Charles Griffin & Company, 1978: 349–369.
23. Flye MW. Venous disorders. In: Sabiston DC Jr, ed. Textbook of Surgery, 14th ed. WB Saunders, 1991: 1490–501.
24. Iba T, Sumpio BE. Morphological response of human endothelial cells subjected to cyclic strain in vitro. Microvasc Res 1991; 42: 245–254.
25. Sumpio BE, Widmann MD. Enhanced production of an endothelium-derived contracting factor by endothelial cells subject to pulsatile stretch. Surgery 1990; 108: 277–282.
26. Leung DYM, Glagov S, Mathews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976; 191: 475–477.
27. Sumpio BE, Banes AJ, Link WG, Johnson G Jr. Enhanced collagen production by smooth muscle cells during repetitive mechanical stretching. Arch Surg 1988; 123: 1233–1236.
28. Mills I, Letsou G, Rabban J, Sumpio B, Gewirtz H. Mechanosensitive adenylate cyclase activity in coronary vascular smooth muscle cells. Biochem Biophys Res Commun 1990; 171: 143–147.
29. Soyombo AA, Angelini GD, Bryan AJ, Jasani B, Newby AC. Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 1990; 137: 1401–1410.
30. Goldberg MR, Joiner PD, Hyman AL, et al. Human greater and canine lateral saphenous veins. Blood Vessels 1975; 12: 89–97.
31. Miller-Schweinitzer E. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy for varicose veins. Naunyn-Schmiedebergs Arch Pharmacol 1984; 327: 299–303.
32. Cardwell RJ, Webb RC. Diabetes and reactivity of isolated human saphenous vein. Clin Phys 1984; 4: 509–517.
33. Lüscher TF, Diederich D, Siebenmann R, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988; 319: 462–467.
34. Thulesius O, Ugaily-Thulesius L, Neglen P, et al. The role of the endothelium in the control of venous tone: Studies on isolated human veins. Clin Phys 1988; 8: 359–366.
35. Harker CT, Ousley PJ, Harris EJ, et al. The effects of cooling on human saphenous vein reactivity to adrenergic agents. J Vasc Surg 1990; 12: 45–49.
36. Schwartz LB, Radic ZS, O'Donohoe MK, Mikat EM, McCann RL, Hagen P-O. Saphenous vein endothelium-dependent relaxation in patients with peripheral vascular disease. Ann Vasc Surg 1992; 6: 425–432.
37. Docherty JR, Hyland L. An examination of 5-hydroxytryptamine receptors in human saphenous vein. Br J Pharmacol 1986; 89: 77–81.
38. Schwartz LB, O'Donohoe MK, Mikat EM, McCann RL, Hagen P-O. Effects of distention and short-term grafting on vasoreactivity in rabbit external jugular veins. Surgery 1991; 110: 146–153.
39. Khatib HE, Lupinetti FM, Sanofsky SJ, Behrendt DM. Production of endothelium-dependent relaxation responses by saphenous vein grafts in the canine arterial circulation. Surgery 1991; 110: 523–528.
40. Ku DD, Caulfield JB, Kirklin JK. Endothelium-dependent responses in long-term human coronary artery bypass grafts. Circulation 1991; 83: 402–411.